Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Phytotec was a Belgian biotechnology company specializing in plant-based technologies, particularly phytoremediation and the production of high-value compounds through plant tissue culture. A spin-off from the Université Catholique de Louvain (UCLouvain), the company focused on using plants to remove pollutants from soil and water, as well as developing botanical extracts for the pharmaceutical and cosmetic industries. Despite its innovative approach to environmental and life science challenges, the company is no longer active. Its legacy remains tied to early European efforts in commercializing phytotechnology and plant-derived secondary metabolites.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Phytotec.